Akso Health Group
NASDAQTotal Valuation
Akso Health Group carries a market capitalization of 144.46M, placing it among publicly traded companies globally. Its enterprise value stands at 232.93M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 144.46M |
| Enterprise Value | 232.93M |
Share Statistics
Akso Health Group currently has 48.82M shares outstanding.
| Shares Outstanding | 48.82M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Akso Health Group trades at a trailing price-to-earnings ratio of 106.59. The price-to-sales ratio is 14.45, and the price-to-book ratio stands at 4.29.
| PE Ratio | 106.59 |
| PS Ratio | 14.45 |
| PB Ratio | 4.29 |
| P/TBV Ratio | 2.23 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Akso Health Group trades at an EV/EBITDA multiple of 101.13 and an EV/FCF ratio of 213.05. The EV/Sales ratio of 15.01 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 101.13 provides insight into valuation relative to core operating earnings.
| EV / Sales | 15.01 |
| EV / EBITDA | 101.13 |
| EV / EBIT | 101.13 |
| EV / FCF | 213.05 |
Financial Position
Akso Health Group maintains a current ratio of 3.15, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 23.52, indicating elevated leverage, while an interest coverage ratio of -23.77 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.15 |
| Quick Ratio | 2.89 |
| Debt / Equity | 23.52 |
| Debt / EBITDA | -0.78 |
| Interest Coverage | -23.77 |
Financial Efficiency
| Return on Equity (ROE) | -39.69 |
| Return on Assets (ROA) | -17.14 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | -4.00M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Akso Health Group's stock has gained approximately 27.08333% over the past 52 weeks. The 50-day moving average sits at 1.67, while the 200-day moving average is 1.67.
| Beta (5Y) | N/A |
| 52-Week Price Change | 27.08333% |
| 50-Day Moving Average | 1.67 |
| 200-Day Moving Average | 1.67 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Akso Health Group generated 15.52M in revenue and converted that into -24.30M in net income, yielding earnings per share of -1.47. EBITDA reached -30.26M, while operating income came in at -30.26M.
| Revenue | 15.52M |
| Gross Profit | 7.50M |
| Operating Income | -30.26M |
| Pretax Income | -28.30M |
| Net Income | -24.30M |
| EBITDA | -30.26M |
| EBIT | -30.26M |
| Earnings Per Share (EPS) | -1.47 |
Balance Sheet
Akso Health Group holds 14.94M in cash and equivalents against 23.61M in total debt, resulting in a net debt position of 5.76M. Total book value stands at 52.22M, with working capital of 25.88M providing operational flexibility.
| Cash & Cash Equivalents | 14.94M |
| Total Debt | 23.61M |
| Net Debt | 5.76M |
| Equity (Book Value) | 52.22M |
| Book Value Per Share | 3.21 |
| Working Capital | 25.88M |
Margins
Akso Health Group operates with a gross margin of 48.33, reflecting its pricing power and cost economics. The operating margin of -194.97 and net profit margin of -156.60 provide insight into operational efficiency.
| Gross Margin | 48.33 |
| Operating Margin | -194.97 |
| Pretax Margin | -182.35 |
| Profit Margin | -156.60 |
| EBITDA Margin | -194.97 |
Stock Splits
Akso Health Group's most recent stock split took place on August 24, 2020 with a 3:1 split ratio.
| Last Split Date | 8/24/2020 |
| Split Ratio | 3:1 |
Scores
Akso Health Group posts an Altman Z-Score of 4.23, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.23 |